EUVIMEDEUVIMED entdecken
Open Access

PRDX1 protects ATM from arsenite-induced proteotoxicity and maintains its stability during DNA damage signaling

Reem Ali, Mashael Algethami, Amera Sheha, Shatha Alqahtani, Ahmad Altayyar, Ayat Lashen, Emad Rakha, Abdallah Alhaj Sulaiman, Srinivasan Madhusudan, Dindial Ramotar

Oncotarget · 2025

DOI: 10.18632/oncotarget.28720 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncotarget, 2025. Verfasst von Reem Ali und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar. Hauptthemen laut MEDLINE: Ataxia Telangiectasia Mutated Proteins, Arsenites, Peroxiredoxins, DNA Damage. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ataxia Telangiectasia Mutated ProteinsArsenitesPeroxiredoxinsDNA DamageHumansSignal TransductionMRE11 Homologue ProteinFemaleDNA-Binding ProteinsCell Line, TumorHistonesDNA Breaks, Double-StrandedDNA Repair EnzymesCell Cycle ProteinsDNA RepairNuclear ProteinsAcid Anhydride Hydrolases

Stichwörter der Autor:innen

cell cyclehomologous recombinationprotein interactionprotein modificationredox signaling

Substanzen

Ataxia Telangiectasia Mutated ProteinsArsenitesATM protein, humanPRDX1 protein, humanarseniteMRE11 Homologue ProteinPeroxiredoxinsMRE11 protein, humanDNA-Binding ProteinsHistones

Autor:innen und Institutionen

  • College of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar.
  • Naaz Coker Ovarian Cancer Research Centre, Biodiscovery Institute, School of Medicine, University of Nottingham, University Park, Nottingham NG7 3RD, UK.
  • Department of Pathology, Nottingham University Hospitals, City Hospital Campus, Nottingham NG5 1PB, UK.
  • Department of Oncology, Nottingham University Hospitals, City Hospital Campus, Nottingham NG5 1PB, UK.

Zitieren

APA

Ali, R., Algethami, M., Sheha, A., Alqahtani, S., Altayyar, A., Lashen, A., Rakha, E., Sulaiman, A. A., Madhusudan, S., & Ramotar, D. (2025). PRDX1 protects ATM from arsenite-induced proteotoxicity and maintains its stability during DNA damage signaling. Oncotarget. https://doi.org/10.18632/oncotarget.28720

Vancouver

Ali R, Algethami M, Sheha A, Alqahtani S, Altayyar A, Lashen A, et al. PRDX1 protects ATM from arsenite-induced proteotoxicity and maintains its stability during DNA damage signaling. Oncotarget. 2025. doi:10.18632/oncotarget.28720

BibTeX
@article{Ali2025,
  author = {Ali, Reem and Algethami, Mashael and Sheha, Amera and Alqahtani, Shatha and Altayyar, Ahmad and Lashen, Ayat and Rakha, Emad and Sulaiman, Abdallah Alhaj and Madhusudan, Srinivasan and Ramotar, Dindial},
  title = {PRDX1 protects ATM from arsenite-induced proteotoxicity and maintains its stability during DNA damage signaling},
  journal = {Oncotarget},
  year = {2025},
  doi = {10.18632/oncotarget.28720}
}
Kostenlos starten →